Artia Global Partners LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001937964
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 48 positions · Total reported value $541.86M · Top-10 concentration 64.5% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 30.4% · 7 new · 2 cut · 8 exited
Active Share (vs S&P 500): 98.5% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +16.1% · vs SPY +1.3% · Prev Value $396.61M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, Artia Global Partners LP disclosed 48 equity positions with a combined reported value of $541.86M. The filing implies a focused portfolio: its ten largest positions account for 64.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were ABVX ($68.82M), INSM ($62.80M), TRVI ($41.23M). By sector, the heaviest allocations are Health Care 94.9%, Industrials 2.0%. Versus the prior quarter, allocation shifted toward Other (+0.8pp).
Versus the prior quarter, Artia Global Partners LP opened 7 new positions, trimmed 2 and fully exited 8, a turnover rate of 30.4% of positions. The portfolio's overlap with the prior quarter was 73% of names.
The largest new positions opened in Q2 2026 were ALKS ($23.52M), XBI ($15.82M), GH ($5.72M).
Of the 8 positions fully exited versus the prior quarter, the largest were LLY ($35.15M), MRNA ($10.16M), TERN ($5.53M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- LLY ELI LILLY · prev qtr: $35.15M
- MRNA MODERNA INC COM · prev qtr: $10.16M
- TERN TERNS PHARMACEUTICALS INC · prev qtr: $5.53M
- ABBV ABBVIE INC · prev qtr: $3.15M
- SLNO SOLENO THERAPEUTICS INC · prev qtr: $2.29M
- BBIO BRIDGEBIO PHARMA INC · prev qtr: $1.51M
- APGE APOGEE THERAPEUTICS INC · prev qtr: $495.43K
- AVTX AVALO THERAPEUTICS INC · prev qtr: $432.52K
Insider Transactions (Form 4)
Latest Artia Global Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Artia Global Partners LP is an SEC-registered 13F filer based in Miami, FL, United States. As of Q2 2026 it reported 48 US equity positions with a combined value of $541.86M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: MIAMI, FL, United States
- SEC registration: 801-125942 (status: Approved), registered 2022-06-23
- Regulatory AUM (Form ADV): $778.89M as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 48 positions · $541.86M reported value (Q2 2026)
- Top 10 holdings = 64.5% of reported value
- Largest position: ABVX (ABIVAX SA) at 12.7%
- Average position size: $11.29M
Sector Tilt
- Health Care 94.9%
- Industrials 2.0%
- (classified holdings cover 97% of value)
Quarterly Activity
- Q2 2026: 7 new, 11 added, 2 reduced, 8 exited
- 28 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
516.45K | $68.82M | 12.70% | Reduce | |
| 2 |
|
589.05K | $62.80M | 11.59% | Add | |
| 3 |
|
2.21M | $41.23M | 7.61% | Add | |
| 4 |
|
517.32K | $36.08M | 6.66% | Add | |
| 5 |
|
185.39K | $34.72M | 6.41% | Add | |
| 6 |
|
29.74K | $27.59M | 5.09% | Hold | |
| 7 |
|
448.96K | $23.52M | 4.34% | New | |
| 8 |
|
339.03K | $19.26M | 3.56% | Add | |
| 9 |
|
98.38K | $18.65M | 3.44% | Add | |
| 10 |
|
503.94K | $17.08M | 3.15% | Hold | |
| 11 |
|
162.99K | $15.89M | 2.93% | Hold | |
| 12 |
|
100.00K | $15.82M | 2.92% | New | |
| 13 |
|
65.12K | $13.80M | 2.55% | Add | |
| 14 |
|
144.38K | $11.45M | 2.11% | Hold | |
| 15 |
|
767.10K | $10.97M | 2.02% | Hold | |
| 16 |
|
278.55K | $7.84M | 1.45% | Reduce | |
| 17 |
|
180.73K | $7.05M | 1.30% | Hold | |
| 18 |
|
59.32K | $6.21M | 1.15% | Add | |
| 19 |
|
70.70K | $6.02M | 1.11% | Add | |
| 20 |
|
46.70K | $6.00M | 1.11% | Hold | |
| 21 |
|
138.51K | $5.77M | 1.06% | Hold | |
| 22 |
|
22.60K | $5.74M | 1.06% | Hold | |
| 23 |
|
38.10K | $5.72M | 1.05% | New | |
| 24 |
|
464.44K | $5.38M | 0.99% | New | |
| 25 |
|
96.28K | $5.30M | 0.98% | Hold | |
| 26 |
|
119.74K | $5.27M | 0.97% | Hold | |
| 27 |
|
17.74K | $4.73M | 0.87% | Hold | |
| 28 |
|
129.80K | $4.59M | 0.85% | Hold | |
| 29 |
|
1.99M | $4.16M | 0.77% | Hold | |
| 30 |
|
98.80K | $4.01M | 0.74% | Add | |
| 31 |
|
18.44K | $3.98M | 0.73% | Hold | |
| 32 |
|
65.00K | $3.92M | 0.72% | Hold | |
| 33 |
|
24.99K | $3.85M | 0.71% | Hold | |
| 34 |
|
137.80K | $3.72M | 0.69% | Hold | |
| 35 |
|
1.81M | $3.69M | 0.68% | Hold | |
| 36 |
|
72.10K | $3.66M | 0.68% | Add | |
| 37 |
|
33.40K | $3.18M | 0.59% | New | |
| 38 |
|
22.95K | $2.81M | 0.52% | Hold | |
| 39 |
|
5.00K | $2.71M | 0.50% | Hold | |
| 40 |
|
38.41K | $2.70M | 0.50% | Hold | |
| 41 |
|
29.20K | $1.87M | 0.34% | Hold | |
| 42 |
|
383.20K | $839.21K | 0.15% | New | |
| 43 |
|
2.50K | $836.98K | 0.15% | Hold | |
| 44 |
|
17.02K | $663.06K | 0.12% | Hold | |
| 45 |
|
42.08K | $612.26K | 0.11% | Hold | |
| 46 |
|
4.90K | $605.15K | 0.11% | Hold | |
| 47 |
|
205.32K | $369.58K | 0.07% | Hold | |
| 48 |
|
4.00K | $355.12K | 0.07% | New | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)
Historical Backtest (10 quarters)
Avg precision 64% · recall 64% · F1 64% · avg rank error 3.4 · Top-10 turnover 36%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 90% | 90% | 90% | NVO · MRK · LLY · ABBV · AZN · ARGX · VKTX · AXSM · NBIX · ITCI | NVO · LLY · MRK · VKTX · ABBV · ITCI · ARGX · AZN · VRTX · AXSM |
| 2024-Q2 | 80% | 80% | 80% | NVO · LLY · MRK · VKTX · ABBV · ITCI · VRTX · ARGX · AZN · OCUL | LLY · MRK · NVO · AZN · ITCI · VRTX · ALNY · VKTX · AXSM · ARGX |
| 2024-Q3 | 80% | 80% | 80% | LLY · MRK · NVO · ITCI · AZN · ALNY · VRTX · VKTX · AXSM · PCVX | NVO · VKTX · ITCI · AZN · SLNO · LLY · ALNY · VRTX · PCVX · ARGX |
| 2024-Q4 | 50% | 50% | 50% | NVO · VKTX · ITCI · SLNO · AZN · LLY · ALNY · PCVX · VRTX · AXSM | SLNO · MRUS · ITCI · ACLX · NUVL · PCVX · ALNY · AZN · RVMD · VRNA |
| 2025-Q1 | 50% | 50% | 50% | SLNO · MRUS · ITCI · NUVL · ACLX · PCVX · RVMD · ALNY · INSM · VRNA | LLY · VRNA · ITCI · INSM · MRUS · PTGX · ACLX · AZN · BSX · DGX |
| 2025-Q2 | 60% | 60% | 60% | LLY · VRNA · ITCI · INSM · MRUS · PTGX · ACLX · AZN · BSX · DGX | ARGX · SLNO · LLY · BSX · MRUS · DGX · AZN · VRNA · XBI · TRVI |
| 2025-Q3 | 50% | 50% | 50% | ARGX · SLNO · LLY · BSX · DGX · MRUS · AZN · VRNA · XBI · TRVI | ARGX · INSM · SLNO · VRNA · QURE · MRUS · UGL · LLY · VRTX · ABVX |
| 2025-Q4 | 50% | 50% | 50% | ARGX · INSM · SLNO · VRNA · QURE · UGL · MRUS · VRTX · LLY · TRVI | INSM · ARGX · LLY · VKTX · TRVI · QURE · NAMS · AZN · CDTX · EYPT |
| 2026-Q1 | 60% | 60% | 60% | INSM · LLY · ARGX · VKTX · QURE · TRVI · NAMS · AZN · EYPT · CDTX | ABVX · INSM · LLY · TRVI · ARGX · AZN · NAMS · DNTH · RVMD · IONS |
| 2026-Q2 ★ | 70% | 70% | 70% | ABVX · INSM · LLY · TRVI · ARGX · NAMS · AZN · DNTH · RVMD · IONS | ABVX · INSM · TRVI · BTSG · RVMD · ARGX · ALKS · TVTX · AZN · NAMS |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did Artia Global Partners LP buy in 2026-Q2?
In its 2026-Q2 13F filing, Artia Global Partners LP reported 48 equity positions worth $541.86M in aggregate; its largest disclosed positions were ABVX ($68.82M), INSM ($62.80M), TRVI ($41.23M).
How large is Artia Global Partners LP's portfolio?
Artia Global Partners LP reported $541.86M of long equity holdings across 48 positions as of 2026-Q2. Top-10 holdings account for 64.5% of reported value.
What is Artia Global Partners LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.